Marc Blaustein

Marc Blaustein

Geen lopende functies

Vermogen: 2 519 $ op 29-02-2024

61 jaar
Health Technology
Consumer Services
Health Services

Profiel

Marc B.
Blaustein
founded Akashi Therapeutics Inc. Mr. Blaustein is former Chief Executive Officer at Akashi Therapeutics Inc, former Chief Executive Officer of Ned Biosystems, Inc., former Chief Operating, Financial & Accounting Officer at Finch Therapeutics Group, Inc., former Founding Partner of Northbridge Consulting, former Head-Business Development of Genetics Institute LLC, former SVP-Manufacturing, Process & Commercial Operations at Dyax Corp.
and former Head-Business Development for Guide Therapeutics, Inc. Marc B.
Blaustein
received a graduate degree from Harvard University and an undergraduate degree from the University of Pennsylvania.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
10-04-2023 933 ( 0.06% ) 2 519 $ 29-02-2024

Eerdere bekende functies van Marc Blaustein

BedrijvenFunctieEinde
FINCH THERAPEUTICS GROUP, INC. Director of Finance/CFO 15-05-2023
Corporate Officer/Principal 01-01-2021
Chief Executive Officer 01-01-2019
Chief Executive Officer 01-01-2017
DYAX CORP. Corporate Officer/Principal 01-01-2009
Ervaring van Marc Blaustein in detail bekijken

Opleiding van Marc Blaustein

Harvard University Graduate Degree
University of Pennsylvania Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Marc Blaustein in detail bekijken

Connecties

26

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
FINCH THERAPEUTICS GROUP, INC.

Health Services

Bedrijven in privébezit6

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Northbridge Consulting

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Marc Blaustein